[1]CurrentPatentAssignee:HINOVAPHARMACEUTICALS-CN109503618,2019,A
[1]CurrentPatentAssignee:HINOVAPHARMACEUTICALS-CN109503618,2019,ALocationinpatent:Paragraph0175;0176;0177;0178
[1]CurrentPatentAssignee:HINOVAPHARMACEUTICALS-CN109503618,2019,ALocationinpatent:Paragraph0180-0183
[1]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2020/86858,2020,A1Locationinpatent:Page/Pagecolumn506
[2]Dragovich,PeterS.;Pillow,ThomasH.;Blake,RobertA.;Sadowsky,JackD.;Adaligil,Emel;Adhikari,Pragya;Bhakta,Sunil;Blaquiere,Nicole;Chen,Jinhua;DelaCruz-Chuh,Josefa;Gascoigne,KarenE.;Hartman,StevenJ.;He,Mingtao;Kaufman,Susan;Kleinheinz,Tracy;Kozak,KatherineR.;Liu,Liang;Liu,Liling;Liu,Qi;Lu,Ying;Meng,Fanwei;Mulvihill,MelindaM.;O'Donohue,Aimee;Rowntree,RebeccaK.;Staben,LeannaR.;Staben,StevenT.;Wai,John;Wang,Jian;Wei,Binqing;Wilson,Catherine;Xin,Jianfeng;Xu,Zijin;Yao,Hui;Zhang,Donglu;Zhang,Hongyan;Zhou,Hao;Zhu,Xiaoyu[JournalofMedicinalChemistry,2021,vol.64,#5,p.2534-2575]
[1]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2020/86858,2020,A1
[2]Dragovich,PeterS.;Pillow,ThomasH.;Blake,RobertA.;Sadowsky,JackD.;Adaligil,Emel;Adhikari,Pragya;Bhakta,Sunil;Blaquiere,Nicole;Chen,Jinhua;DelaCruz-Chuh,Josefa;Gascoigne,KarenE.;Hartman,StevenJ.;He,Mingtao;Kaufman,Susan;Kleinheinz,Tracy;Kozak,KatherineR.;Liu,Liang;Liu,Liling;Liu,Qi;Lu,Ying;Meng,Fanwei;Mulvihill,MelindaM.;O'Donohue,Aimee;Rowntree,RebeccaK.;Staben,LeannaR.;Staben,StevenT.;Wai,John;Wang,Jian;Wei,Binqing;Wilson,Catherine;Xin,Jianfeng;Xu,Zijin;Yao,Hui;Zhang,Donglu;Zhang,Hongyan;Zhou,Hao;Zhu,Xiaoyu[JournalofMedicinalChemistry,2021,vol.64,#5,p.2534-2575]
Title: Synergistic antitumor activity of lenalidomide with the BET bromodomain inhibitor CPI203 in bortezomib-resistant mantle cell lymphoma.
Journal: Leukemia 20141001
Title: The bromodomain and extra-terminal inhibitor CPI203 enhances the antiproliferative effects of rapamycin on human neuroendocrine tumors.
Journal: Cell death & disease 20141001
Title: Blockade of oncogenic IκB kinase activity in diffuse large B-cell lymphoma by bromodomain and extraterminal domain protein inhibitors.
Journal: Proceedings of the National Academy of Sciences of the United States of America 20140805
Title: BRD4 is an atypical kinase that phosphorylates serine2 of the RNA polymerase II carboxy-terminal domain.
Journal: Proceedings of the National Academy of Sciences of the United States of America 20120501
Title: Devaiah BN, et al. BRD4 is an atypical kinase that phosphorylates serine2 of the RNA polymerase II carboxy-terminal domain. Proc Natl Acad Sci U S A. 2012 May 1;109(18):6927-32.
Title: Moros A, et al. Synergistic antitumor activity of lenalidomide with the BET bromodomain inhibitor CPI203 in bortezomib-resistant mantle cell lymphoma. Leukemia. 2014 Oct;28(10):2049-59
